📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Genovis

1.1 - Company Overview

Genovis Logo

Genovis

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of SmartEnzymes enabling identification, characterization, and quality control of antibody-based biotherapeutics, including monoclonal antibodies, ADCs, and biosimilars. Offerings include FabRICATOR for rapid antibody digestion, FabALACTICA for IgG1 Fab profiling, TransGLYCIT for site-specific IgG glycan remodeling, SialEXO for mucin glycan engineering, and GlySERIAS for fusion protein analysis, plus technical support.

Products and services

  • TransGLYCIT: A platform-scale technology that efficiently and site-specifically remodels human IgG glycans to produce antibodies with defined glycoforms, enabling controlled glycan engineering for therapeutic characterization
  • FabRICATOR: A biotech-grade enzyme that digests antibodies to enable rapid characterization in pharmaceutical research and development, accelerating analyses of antibody-based biotherapeutics with higher quality than competing technologies
  • SmartEnzymes: An industrial-grade range of enzyme products engineered for development and quality control of biological drugs, enabling faster, higher-quality identification and characterization of antibody-based biotherapeutics including monoclonal antibodies, ADCs, and biosimilars

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Genovis

Scienion Logo

Scienion

HQ: Germany Website
  • Description: Provider of ultra-low volume liquid handling systems and microarray technologies enabling multiparallel bioanalytics, high throughput screening, and high throughput microarray production in genomics. Offerings include automated dispensers (sciFLEXARRAYER), pico- to microliter non-contact printing (sciDROP PICO), single-cell isolation (CellenONE), functionalized slides (sciCHIPs), buffers (sciBUFFERs), and consumables.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Scienion company profile →
Celltrio Logo

Celltrio

HQ: United States Website
  • Description: Provider of cell culturing automation and biobanking solutions via RoboCell, a cell line automation platform for cell maintenance, culture and screening; Bioflow, software to define, schedule, execute and monitor workflows with real-time data tracking; and RoboStor, automated LN2 storage for biobanking and cryogenic applications, standalone or integrated with RoboCell.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Celltrio company profile →
Visikol Logo

Visikol

HQ: United States Website
  • Description: Provider of CRO services focused on digital pathology, 3D tissue imaging, and 3D cell culture assays/models. Delivers end-to-end 2D/3D in vitro models, tissue clearing (Visikol HISTO) and confocal microscopy, high content screening, bio-imaging, bioinformatics and image analysis, plus custom drug discovery solutions and 21 CFR Part 11 compliant digital pathology software.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Visikol company profile →
Cellesce Logo

Cellesce

HQ: United Kingdom Website
  • Description: Provider of patient-derived organoid (PDO) technology and 3D organoids for drug discovery assays, offering fee-for-service custom development and scaled manufacturing of PDO lines, plus comprehensive enablement services including sourcing, line development, technology access, and quality management systems. Biochemical engineering expertise in cell expansion; based in Cardiff, UK.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Cellesce company profile →
Clean Cells Logo

Clean Cells

HQ: France Website
  • Description: Provider of biosafety and quality control testing for biopharmaceuticals, including vaccines, monoclonal antibodies, and cell and gene therapies; GMP manufacturing of cell and virus banks and Master/Working Cell Banks; secure GMP and non-GMP storage; development of cytotoxicity potency assays; purity and identity testing; and production of experimental drugs such as cell therapy products and therapeutic phages.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Clean Cells company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Genovis

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Genovis

2.2 - Growth funds investing in similar companies to Genovis

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Genovis

4.2 - Public trading comparable groups for Genovis

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Genovis

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Genovis

What does Genovis do?

Genovis is a provider of SmartEnzymes enabling identification, characterization, and quality control of antibody-based biotherapeutics, including monoclonal antibodies, ADCs, and biosimilars. Offerings include FabRICATOR for rapid antibody digestion, FabALACTICA for IgG1 Fab profiling, TransGLYCIT for site-specific IgG glycan remodeling, SialEXO for mucin glycan engineering, and GlySERIAS for fusion protein analysis, plus technical support.

Who are Genovis's competitors?

Genovis's competitors and similar companies include Scienion, Celltrio, Visikol, Cellesce, and Clean Cells.

Where is Genovis headquartered?

Genovis is headquartered in United States.

How many employees does Genovis have?

Genovis has 1,000 employees 🔒.

When was Genovis founded?

Genovis was founded in 2010 🔒.

What sector and industry vertical is Genovis in?

Genovis is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Genovis

Who are the top strategic acquirers in Genovis's sector and industry

Top strategic M&A buyers and acquirers in Genovis's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Genovis?

Top strategic M&A buyers groups and sectors for Genovis include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Genovis's sector and industry vertical

Which are the top PE firms investing in Genovis's sector and industry vertical?

Top PE firms investing in Genovis's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Genovis's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Genovis's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Genovis's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Genovis include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Genovis's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Genovis?

The key public trading comparables and valuation benchmarks for Genovis include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Genovis for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Genovis with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Genovis's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Genovis with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Genovis's' sector and industry vertical?

Access recent funding rounds and capital raises in Genovis's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Genovis